title: High volume hemofiltration in critically ill patients: why, when and how?
authors.affiliation: Research Extracorporeal Therapies, Fresenius Medical Care Deutschland GmbH, Bad Homburg, Germany. ciro.tetta@fmc-ag.com
authors.forename: Ciro
authors.initials: C
authors.lastname: Tetta
authors.forename: Rinaldo
authors.initials: R
authors.lastname: Bellomo
authors.forename: John
authors.initials: J
authors.lastname: Kellum
authors.forename: Zaccaria
authors.initials: Z
authors.lastname: Ricci
authors.forename: Robert
authors.initials: R
authors.lastname: Pohlmeiere
authors.forename: Jutta
authors.initials: J
authors.lastname: Passlick-Deetjen
authors.forename: Claudio
authors.initials: C
authors.lastname: Ronco
mesh_terms: D016638:Critical Illness / Q000628:therapy*; D006440:Hemofiltration / Q000379:methods; D006801:Humans